Target intelligence / Profile preview

Influenza virus nucleoprotein (NP)

Target
NP
Molecular classification
Other (structural viral protein), RNA-binding protein
01

Overview

Influenza virus nucleoprotein (NP) is a major structural protein essential for the influenza virus life cycle. It encapsidates the viral RNA genome to form ribonucleoprotein (RNP) complexes, protecting the genome and regulating critical steps in transcription and replication. NP interacts directly with the viral RNA polymerase subunits (PB1, PB2) and is required for the switch between viral RNA transcription and replication. NP self-associates through defined protein-protein interfaces (notably a tail loop), forming rod-shaped, flexible RNP structures that are necessary for genome stability and function. NP also contains nuclear localization signals for import of the viral genome into the host nucleus, where replication occurs. Owing to its essential and conserved role, NP is an attractive antiviral target and is broadly used as a diagnostic antigen for influenza infection

Other names
Influenza nucleoproteinviral nucleoproteinNP protein
02

Mechanism of action

Most drug candidates act by inhibiting NP oligomerization or RNA binding, disrupting viral RNP assembly and genome replication

03

Biological functions

Genome packaging and encapsidation of viral RNARegulation of viral transcription and replicationNuclear import of viral ribonucleoprotein complexesOligomerization for ribonucleoprotein (RNP) assembly
04

Disease associations

Infection (influenza virus)
05

Safety considerations

Therapeutic targeting of NP presents challenges due to high protein conservation across strains and essential function, raising concerns related to resistance development.Off-target effects are uncertain since NP is virus-specific, but toxicity risk may arise if therapies affect structurally similar host factors
06

Interacting drugs

No approved small molecule therapeutics currently target NP directly, but several investigational and experimental compounds have been reported with anti-influenza NP activity (e.g., nucleozin, naproxen in research context)
07

Biomarkers

NP antigen is widely used as a diagnostic biomarker (via rapid influenza diagnostic tests and immunoassays) to detect influenza infection but is not established as a companion diagnostic in therapeutics.

Beyond the preview

Go deeper on Influenza virus nucleoprotein (NP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza virus nucleoprotein (NP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call